Mast Cell Density,Hepatic Stellate Cell Activation and TGF-β1 Transcripts in the Aging Sprague-Dawley Rat During Early Acute Liver Injury

Abstract

Mast cells (MCs) have been indicated as a source of various inflammatory cytokines, chemokines and growth factors. This study evaluates liver tissue MC density as a quantitative marker of acute liver inflammation in 2- and 19-month old rats treated with carbon tetrachloride (CCl4) to assess the relationships between MC density, hepatocellular damage, mRNA encoding TGF-β ₁, hepatic stellate cell (HSC) activation and collagen levels. Consecutive histological sections from each age group were stained with toluidine blue to identify granulated MCs, Direct Red 80 to recognize collagen matrix, and by immunohistochemistry to identify activated hepatic stellate cells (HSCs), which were subsequently counted by means of a computer-aided image analysis. Histology showed hepatocellular necrosis with inflammatory cell infiltration and collagen matrix deposition. Two and 24 hours after intoxication, MC density had considerably increased in the younger rats, but less in those aged 19 months. Although the untreated older rats had a larger area occupied by activated HSCs than the untreated younger rats, the increase in the number of HSCs was greater in the younger rats both two and 24 hours after intoxication. The greater MC density in younger rats suggests that older rats have a reduced immune response or recruit fewer MCs. The activated HSCs and TGF-β1 transcripts did not increase significantly during the study period, thus indicating that these are later events in chemically induced hepatic toxicity. In conclusion, MC density may be an index of acute liver inflammation after CCl4 intoxication.

Keywords

Liver mast cells hepatic stellate cells myofibroblasts CCl4 intoxication inflammation collagen synthesis transforming-growth factor-b1.

References

Akiyoshi H. , Terada T. (1998). Mast cells, myofibroblasts and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 29: 112—119.

Atkins FM , Clark RA (1987). Mast cells and fibrosis. Arch Dermatol 123: 191—193.

Bataller R. (2001). Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 21: 437—451.

Benyon RC (1999). Mast cells in the liver. Clin Exper Allergy 29: 155—158.

Di Girolamo N. , Wakefield D. (2000). In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Develop Immunol 7: 131—142.

Doi K. , Kurabe S. , Shimazu N. , Inagaki M. (1991). Systemic histopathology of rats with CCl4-induced hepatic cirrhosis. Lab Animal 25: 21—25.

Farrell DJ , Hines JE , Walls AF , Kelly PJ , Bennett MK , Burt AD ( 1995). Intrahepatic mast cells in chronic liver diseases. Hepatology 22: 1175— 1181.

Fodinger M. , Fritsch G. , Winkler K. , Emminger W. , Mitterbauer G. , Gadner H. , Valent P. , Mannhalter C. (1994). Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogenic bone marrow transplantation. Blood 84: 2954—2959.

Gaca MDA , Pickering JA , Arthur MJP , Benyon RC (1999). Human ans rat hepatic stellate cells produce stem cell factor: A possibile mechanism for mast cell recruitment in liver fibrosis . J Hepatology 30: 850— 858.

10.

Gagliano N. , Arosio B. , Grizzi F. , Masson S. , Tagliabue J. , Dioguardi N. , Vergani C. , Annoni G. (2002). Reduced collagenolytic activity of matrix metalloproteinases and development of liver fibrosis in the aging rat. Mech Ageing Dev 123: 413—425.

11.

Galli SJ (2000). Mast cells and basophils. Curr Opin Hematol 7: 32—39.

12.

Grizzi F. , Franceschini B. , Gagliano N. , Barbieri B. , Arosio B. , Annoni G. , Chiriva-Internati M. , Dioguardi N. (2002). Mast cell density: A quantitative index of liver acute inflammation. Anal Quant Cytol Histol 24: 63—69.

13.

Hoffman J. , Himes MB , Lapan S. , etal (1955). Responses ofthe liverto injury. Effects of acute carbon tetrachloride poisoning. Arch Pathol 59: 429—438.

14.

Iredale JP (2001). Hepatic stellate cell behaviour during resolution of liver injury. Semin Liver Dis 21: 427—436.

15.

Matsunaga Y. , Terada T. (2000). Mast cell subpopulations in chronic inflammatory hepatobiliary diseases. Liver 20: 152—156.

16.

Metcalfe DD , Baram D. , Mekori Y. (1997). Mast cells. Physiol Rev 77: 1033—1079.

17.

Onori P. , Morini S. , Franchitto A. , Sferra R. , Alvaro D. , Gaudio E. (2000). Hepatic microvascular features in experimental cirrhosis: A structural and morphometrical study in CCl4-treated rats. J Hepatol 33: 555—563.

18.

Rioux KP , Sharkey KA , Wallace JL (1996). Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 23: 888— 895.

19.

Sherlock S. (1970). Causes and effects of acute liver damage. Scand J Gastroenterol 5: 187—202.

20.

Strobel S. , Miller HRP , Ferguson A. (1981). Human intestinal mucosal mast cells: Evaluation of fixation and staining techniques. J Clin Pathol 34: 851—858.

21.

Sugihara A. , Tsujimura T. , Fujita Y. , Nakata Y. , Terada N. (1999). Evaluation of role of mast cells in the development of liver fibrosis using mast celldeficient rats and mice. J Hepatol 30: 859—867.

22.

Terada T. , Matsunaga Y. (2000). Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 33: 961— 966.

23.

Uddin Ahmed AF , Ohtani H. , Nio M. , Funaki N. , Sasaki H. , Nagura H. , Ohi R. (2000). Intrahepatic mast cell population correlates with clinical outcome in biliary atresia. J Ped Surg 35: 1762—1765.

24.

Zimmermann A. , Zhao D. , Reichen J. (1999). Myofibroblasts in the cirrhotic rat liver reflect hepatic remodelling and correlate with fibrosis and sinusoidal capillarization. J Hepatol 30: 646—652.